Webinar: Tech Transfer For Viral Vectors
When? May 16th, 16.00 CET
This webinar delves into the exciting world of Tech Transfer and how it can help bring cutting-edge scientific research from academia to the clinic, where it can impact people’s lives.
Whether you’re a researcher, a biotech entrepreneur, or a viral vector enthusiast, this webinar is not to be missed. You will have the opportunity to learn from the best, ask questions, and access our resources.
So, register now and be a part of this exciting session to help navigate the road from academia to the clinic.
Key learnings:
- Tech Transfer in an ideal world
- Commonly encountered challenges
- How you can prepare for a smooth transition.
- Showcase materials and best practices from the field
Monika Ballmann, Ph.D.
Dr Ballmann is the Associate Director of the Viral Vector and Vaccine Development Department at Batavia Biosciences. She is responsible for viral vaccine and viral vector development programs, small-scale process development studies, and the production of pre-GMP grade viral vaccine and vector batches.
During the past 12 years, she held diverse positions in virology and process development at Batavia Biosciences and the Hungarian Academy of Sciences. In addition, she has worked in several international consortia, including both for-profit and non-profit programs. She was involved in the development and production of several products, among many others, adenovirus-, measles-, and arenavirus-based viral vectors, poliovirus, SARS-CoV-2 and measles vaccines.
Dr Ballmann holds a PhD in veterinary virology and is (co-)author of 13 scientific publications.
